Acta Pharmaceutica Sinica B

115.3k citations
2.6k papers · · active since 2011

Impact in

Papers in

Acta Pharmaceutica Sinica B

2.4k papers receiving 112.9k citations

Peers

Acta Pharmaceutica Sinica B
Comparison fields: 5 of 212
  • Pharmaceutical Science 10.7k
  • Drug Discovery 413
  • Biomaterials 15.4k
  • Complementary and alternative medicine 4.6k
  • Molecular Biology 27.4k
Replace Drug Design Development and Therapy with:
Drug Design Development and Therapy China
Drug Discovery Today United States
Critical Reviews in Food Science and Nutrition China
Archives of Pharmacal Research South Korea
The AAPS Journal United States
Toxicology in Vitro United States
Acta Pharmacologica Sinica China
Theranostics China
Journal of Nanobiotechnology China
Current Topics in Medicinal Chemistry United States
Acta Pharmaceutica Sinica B relative to Drug Design Development and Therapy China Drug Design Development and Therapy's profile →
Citations per field
00.5×1.5×2×2.4×
Drug Design Development and Therapy · 1×
Citations per year

Countries where authors publish in Acta Pharmaceutica Sinica B

Since Specialization
Citations

This map shows the geographic impact of research published in Acta Pharmaceutica Sinica B. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Acta Pharmaceutica Sinica B with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Acta Pharmaceutica Sinica B more than expected).

Fields of papers published in Acta Pharmaceutica Sinica B

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Acta Pharmaceutica Sinica B. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Acta Pharmaceutica Sinica B.

About Acta Pharmaceutica Sinica B

The 2.6k papers published in Acta Pharmaceutica Sinica B in the last decades have received a total of 115.3k indexed citations . Papers published in Acta Pharmaceutica Sinica B usually cover Biomaterials (309 papers), Pharmaceutical Science (171 papers), Pharmacology (124 papers), Molecular Biology (772 papers) and Complementary and alternative medicine (108 papers) specifically the topics of Nanoparticle-Based Drug Delivery (298 papers), Nanoplatforms for cancer theranostics (179 papers), Cancer Immunotherapy and Biomarkers (98 papers), Advanced Drug Delivery Systems (87 papers), Traditional Chinese Medicine Analysis (82 papers), Pharmacogenetics and Drug Metabolism (80 papers), RNA Interference and Gene Delivery (79 papers) and Drug Transport and Resistance Mechanisms (78 papers). The most active scholars publishing in Acta Pharmaceutica Sinica B are Wei Li, Huile Gao, Xiangming Guan, Vijaykumar Nekkanti, Zongru Guo, Ningning Yang, Venkatareddy Nadithe, Liwu Fu, Wei Wu and Duxin Sun.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact